In a nested case-control study by de Martel et al. [14], a very high concentration (>3200 pg/ml) of serum ghrelin was associated with a lower risk of esophageal adenocarcinoma, a finding was unexpected even to the authors themselves. The gene discussed is GHRL; the disease is esophageal adenocarcinoma.